Literature DB >> 29199528

Gene networks associated with non-syndromic intellectual disability.

Soohyun Lee1, Stephen Rudd2, Jacob Gratten3, Peter M Visscher3, Johannes B Prins1, Paul A Dawson1.   

Abstract

Non-syndromic intellectual disability (NS-ID) is a genetically heterogeneous disorder, with more than 200 candidate genes to date. Despite the increasing number of novel mutations detected, a relatively low number of recurrently mutated genes have been identified, highlighting the complex genetic architecture of the disorder. A systematic search of PubMed and Medline identified 245 genes harbouring non-synonymous variants, insertions or deletions, which were identified as candidate NS-ID genes from case reports or from linkage or pedigree analyses. From this list, 33 genes are common to syndromic intellectual disability (S-ID) and 58 genes are common to certain neurological and neuropsychiatric disorders that often include intellectual disability as a clinical feature. We examined the evolutionary constraint and brain expression of these gene sets, and we performed gene network and protein-protein interaction analyses using GeneGO MetaCoreTM and DAPPLE, respectively. The 245 NS-ID candidate genes were over-represented in axon guidance, synaptogenesis, cell adhesion and neurotransmission pathways, all of which are key neurodevelopmental processes for the establishment of mature neuronal circuitry in the brain. These 245 genes exhibit significantly elevated expression in human brain and are evolutionarily constrained, consistent with expectations for a brain disorder such as NS-ID that is associated with reduced fecundity. In addition, we report enrichment of dopaminergic and glutamatergic pathways for those candidate NS-ID genes that are common to S-ID and/or neurological and neuropsychiatric disorders that exhibit intellectual disability. Collectively, this study provides an overview and analysis of gene networks associated with NS-ID and suggests modulation of neurotransmission, particularly dopaminergic and glutamatergic systems as key contributors to synaptic dysfunction in NS-ID.

Entities:  

Keywords:  Idiopathic intellectual disability; dopaminergic; genetics; glutamatergic; neurodevelopment; neurotransmission

Mesh:

Year:  2017        PMID: 29199528     DOI: 10.1080/01677063.2017.1404058

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  5 in total

1.  Neurocognitive functioning of children with mild to borderline intellectual disabilities and psychiatric disorders: profile characteristics and predictors of behavioural problems.

Authors:  E Santegoeds; E van der Schoot; S Roording-Ragetlie; H Klip; N Rommelse
Journal:  J Intellect Disabil Res       Date:  2021-08-11

Review 2.  Rho GTPases in Intellectual Disability: From Genetics to Therapeutic Opportunities.

Authors:  Valentina Zamboni; Rebecca Jones; Alessandro Umbach; Alessandra Ammoni; Maria Passafaro; Emilio Hirsch; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

3.  A Novel LINS1 Truncating Mutation in Autosomal Recessive Nonsyndromic Intellectual Disability.

Authors:  Babylakshmi Muthusamy; Anikha Bellad; Pramada Prasad; Aravind K Bandari; G Bhuvanalakshmi; R M Kiragasur; Satish Chandra Girimaj; Akhilesh Pandey
Journal:  Front Psychiatry       Date:  2020-05-18       Impact factor: 4.157

Review 4.  Hypoxia and connectivity in the developing vertebrate nervous system.

Authors:  Joshua L Bonkowsky; Jong-Hyun Son
Journal:  Dis Model Mech       Date:  2018-12-12       Impact factor: 5.758

5.  Identification of a novel nonsense homozygous mutation of LINS1 gene in two sisters with intellectual disability, schizophrenia, and anxiety.

Authors:  Chia-Hsiang Chen; Yu-Shu Huang; Ting-Hsuan Fang
Journal:  Biomed J       Date:  2021-08-24       Impact factor: 4.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.